1.212
price down icon3.81%   -0.048
 
loading

Finanzdaten der Bone Biologics Corp-Aktie (BBLG)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
2.49%
0.7331
0.7153 0.7481 1.0385 1.5549
Operating Income/Loss
2.49%
-0.7331
-0.7153 -0.7481 -1.0385 -1.5549
Nonoperating Income/Loss
0.15%
0.0485
0.0485 0.00756 0.0214 0.0332
Income/Loss From Continuing Operations Before Tax
4.99%
-0.70
-0.6667 -0.7405 -1.0171 -1.5217
Income/Loss From Continuing Operations After Tax
4.99%
-0.70
-0.6667 -0.7405 -1.0171 -1.5217
Net Income/Loss
4.99%
-0.70
-0.6667 -0.7405 -1.0171 -1.5217
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-0.0154
- - - -
Basic Average Shares
88.35%
0.2091
1.7951 0.5578 3.1832 0.3209
Diluted Average Shares
88.35%
0.2091
1.7951 0.5578 3.1832 0.3209
Basic Earnings Per Share
62.16%
-0.14
-0.37 -1.33 -0.32 0.02
Diluted Earnings Per Share
62.16%
-0.14
-0.37 -1.33 -0.32 0.02
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$46.06
price up icon 0.41%
$28.99
price up icon 1.33%
$54.07
price up icon 1.61%
$90.20
price up icon 0.16%
$141.15
price up icon 1.23%
biotechnology ONC
$288.30
price up icon 0.99%
Kapitalisierung:     |  Volumen (24h):